NCT02856230View on ClinicalTrials.gov

An Efficacy and Safety Study to Evaluate Ranger DEB for BTK Angioplasty in Patients With CLI (RANGER-BTK)

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

May 31, 2018

Study Completion Date

November 30, 2018

Conditions
Lower Limb IschemiaPeripheral Vascular Diseases
Interventions
DEVICE

Ranger SL DEB

BTK angioplasty using Ranger SL DEB

Trial Locations (1)

75908

AP-HP - Hopital Europeen Georges-Pompidou Paris, France, Paris

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER